✨ Free AI Report
Absci Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Absci Corporation
Company Research

Absci Corporation: Business Overview, Financials & Competitive Analysis

Absci Corporation scores 6/10 on the AskCyborg Cyborg Score (Solid). AI-powered biotech platform with scalable technology and strong pharma partnerships, but execution risk on clinical pipeline remains. Absci specializes in using generative AI combined with wet lab technologies to design and validate novel biologic therapeutics, representing a differentiated platform approach. However, the company is early-stage with quarterly losses and requires.

What is Absci Corporation's industry? Absci Corporation (absci.com) operates in Synthetic Biology & AI-Powered Drug Discovery. AskCyborg classifies Absci Corporation under Synthetic Biology & AI-Powered Drug Discovery in its company registry.

Absci is a synthetic biology company leveraging generative AI and scalable wet lab technologies to revolutionize the discovery and design of novel biologics through its Integrated Drug Creation™ platform, which seamle...

6/ 10Solid

Cyborg Score thesis

AI-powered biotech platform with scalable technology and strong pharma partnerships, but execution risk on clinical pipeline...

Read the full analyst-debate transcript →
Industry Synthetic Biology & AI-Powered Drug Discovery
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Absci Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Absci Corporation

AskCyborg analysts argue the bull and bear cases for Absci Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Absci Corporation OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Absci Corporation Overview

Pro stress-test →

Absci is a synthetic biology company leveraging generative AI and scalable wet lab technologies to revolutionize the discovery and design of novel biologics through its Integrated Drug Creation™ platform, which seamlessly unifies biological drug discovery and cell line development. The company screens billions of cells per week and validates AI-designed antibodies in a matter of weeks.

Strategic Profile

Pro stress-test →

Absci targets large pharmaceutical companies developing biologics and therapeutic proteins, as well as emerging and established biotechnology companies seeking advanced protein engineering solutions. The company's technology-forward strategy creates a scalable model applicable in human therapeutics and expanding into adjacent markets such as veterinary medicine.

Competitive Landscape

Pro stress-test →

Absci competes in the AI-powered drug discovery and synthetic biology space against companies like Genentech/Roche, Moderna, Sesen Bio, and emerging AI biotech startups. Differentiation comes from integrated wet lab validation capabilities combined with generative AI, positioning it as a platform play rather than a single-asset company.

Industry Context

Absci Corporation operates in Synthetic Biology & AI-Powered Drug Discovery.

Key facts

Founded: 2011 · Headquarters: Vancouver, Washington · Employees: 194 · Revenue: $35M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Absci Corporation.

  • Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash now sufficient to fund operations into the first half of 2028
  • Collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices for joint R&D activities
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Announced Q4 2025 and full year 2025 financial results scheduled for March 24, 2026
  • August 2025Expanded AI Drug Discovery collaboration with Almirall, a dermatology-focused pharma company, selecting second target
  • +1 moreTrack every material event for Absci Corporation as it happens. Explore monitoring →
Get alerted when Absci Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Drug Discovery PlatformEstablished pharma with AI drug discovery capabilities→mRNA Technology PlatformPlatform-based biotech with AI-enabled design→Cell EngineeringCell therapy and protein design competitor→

Compare Absci Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Absci Corporation operates in Synthetic Biology & AI-Powered Drug Discovery. See how the rest of the sector scores on the Cyborg framework.

Browse Synthetic Biology & AI-Powered Drug Discovery research →
NEW · MCP server

Ask your AI assistant about Absci Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Absci Corporation and its top competitor on Cyborg Score”
“What did Absci Corporation do this quarter?”
“Is Absci Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Absci Corporation do?+
Absci is a synthetic biology company leveraging generative AI and scalable wet lab technologies to revolutionize the discovery and design of novel biologics through its Integrated Drug Creation™ platform, which seamle...
What is Absci Corporation's Cyborg Score?+
Absci Corporation has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Absci Corporation's main competitors?+
Named competitors include Drug Discovery Platform, mRNA Technology Platform, Cell Engineering. The full competitive landscape is in the AskCyborg report.
How can I get the full Absci Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Absci Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Absci Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.